who were not receiving surgery to remove the bladder (cystectomy) and nearby lymph nodes, has been discontinued after it showed no improvement over the standard chemoradiation treatment for this ...

Years later, Harsh returned to the hospital suffering from paraparesis (partial paralysis of the lower limbs) and neurogenic ...

During a live event, Matthew Galsky, MD discussed neoadjuvant and adjuvant options for a patient case including nivolumab or ...

Aumolertinib is a third generation EGFR tyrosine kinase inhibitors, approved for use in patients with advanced EGFR-mutant non-small cell lung cancer (NSCLC). Here, the authors report a phase 2 ...

NIAGARA compared Imfinzi plus chemo to chemo alone in muscle-invasive bladder cancer (MIBC) patients scheduled for a cystectomy to remove the bladder. According to the top-line results ...

At least 15 women from low-income backgrounds visit the outpatient department at Cama and Albless Hospital every month with complaints of persistent pelvic pain, irregular bleeding, and unexplained in ...

The current treatment paradigm of both non-muscle and muscle invasive bladder cancer is highly toxic and morbid ... in BCG-unresponsive high-risk NMIBC patients ineligible for or refusing radical ...

Seaford resident Emma Godden will be taking on the London Marathon on Sunday 27 April to support cancer patients and those ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

Causes: A cyst is a fluid-filled sac that develops inside ... which hold in place the pelvic organs - uterus, bladder, rectum, urethra, and others - weaken, allowing organs in the area to push ...

The hospital is committed to delivering top quality care to patients The General Surgery Department at Zulekha Hospital Dubai ...